Expression of p53 protein in advanced head and neck squamous cell carcinoma before and after chemotherapy

Archives of Otolaryngology - Head and Neck Surgery

Volumn 123, Issue 11, 1997, Pages 1223-1225

  Dimph, Chérie H ^a,d   Dunphy, Frank R ^b   Boyd, James H ^b   Varvares, Mark A ^b   Kim, Han J ^b   Lowe, Val ^b   Teresa, L ^c   Dunleavy, R N ^a   Rodriguez, Jack ^b   McDonough, Erin M ^b  

^a Departments of Pathology

^b Department of Internal Medicine ^*

^c SAINT LOUIS UNIVERSITY   (United States)

^d SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; PACLITAXEL; PROTEIN P53;

ADOLESCENT; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

EID: 9844256089     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.1997.01900110077010     Document Type: Article

References (16)

1. Crawford LV, Pirn DC, Gurney EC, Goodfellow P, Taylor-Papadimitriou J. Detection of a common feature in several human tumor cell lines: a 53,000 Dalton protein. Proc Natl Acad Sci U S A. 1981:78:41-45.
2. Dippold WG, Jay G, DeLeo AB, Khoury G, Old LJ. p53 transformation-related protein: detection by monoclonal antibody in mouse and human cells. Proc Natl Acad Sci USA. 1981;78:1695-1699.
3. Iggo R, Gatter K, Bartek J, Lane D, Harris AL Increased expression of mutant forms of p53oncogene in primary lung cancer. Lancet. 1990:335:675-679.
4. Nigro JM, Baker SJ, Priesinger AC, et al. Mutations in the p53 gene occur in diverse human tumour types. Nature. 1989;342:705-708.
5. Wynford-Thomas D. p53 in tumour pathology: can we trust immunohistochemistry? J Pathol. 1992;166:329-330.
6. Hall PA, Lane DP. p53 in tumour pathology: can we trust immunohistochemistry? J Pathol. 1994;172:1-4.
7. Field JK, Spandidos DA, Malliri A, Gosney JR, Yiagnisis M, Stell PM. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br J Cancer. 1991;64:573-577.
8. Maestro R, Dolcetti R, Gasparotto D. High frequency of p53gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene. 1992:7:1159-1166.
9. Nylander K, Stenling R, Gustafsson H, Zackrisson B, Roos G. p53 expression and cell proliferation in squamous cell carcinomas of the head and neck. Cancer. 1995:75:87-93.
10. Koch WM, Brennan JA, Zahurak M, et al. p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma. J Natl Cancer Inst. 1996; 88:1580-1586.
11. Lavieille JP, Brambilla E, Riva-Lavieille C, Reyt E, Charachon R, Brambilla C. Immunohistochemical detection of p53 protein in preneoplastic lesions and squamous cell carcinoma of the head and neck. Acta Otolaryngol (Stockh). 1995; 115:334-339.
12. Shin DM, Lee JS, Lippman SM, et al. p53 expression: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma. J Natl Cancer ter. 1996;88:519-529.
13. Salvatori P, Costa A, Veneroni S, Faranda A, Molinari R, Silvestrini R. S-phase cell fraction, p53, and bcl-2, prognostic indicators in advanced oral cavity cancer. Head Keck. 1994;16:510. Abstract.
14. Gasparini G, Weidner N, Maluta S, et al. Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous cell carcinoma. IntJ Cancer. 1993:55:739-744.
15. Lowe SW, Bodis S, McClatchey A, et al. p53 status and the efficacy of cancer therapy in vivo. Science. 1994:266:807-810.
16. Lee JM, Bernstein A. p53 mutations increase resistance to ionizing radiation. Proc Natl Acad Sci U S A. 1993:90:5742-5746.